tiprankstipranks
I-Tech AB (SE:ITECH)
:ITECH
Sweden Market
Want to see SE:ITECH full AI Analyst Report?

I-Tech AB (ITECH) Price & Analysis

3 Followers

ITECH Stock Chart & Stats

kr53.80
-kr1.50(-1.91%)
At close: 4:00 PM EST
kr53.80
-kr1.50(-1.91%)

Bulls Say, Bears Say

Bulls Say
Profitable GrowthRecent growth combined with strong profitability indicates effective commercialization and operating leverage. If sustained, this earnings base can support reinvestment and widen the company’s ability to scale Selektope adoption.
Debt-free Balance SheetThe absence of debt materially reduces refinancing and interest-rate risk while preserving financial flexibility. A conservatively funded balance sheet gives I-Tech greater capacity to support product development, regulatory work and commercial expansion.
Strong Cash ConversionStrong conversion of accounting earnings into cash improves the quality of reported profits and provides internally generated funding. Continued positive cash generation can support growth initiatives without requiring debt or dilutive external capital.
Bears Say
Revenue And Margin VolatilityThe weaker 2025 revenue and gross-margin profile shows that earnings may remain sensitive to customer mix, pricing and costs. Such variability can make future profitability less predictable even while the recent TTM performance remains strong.
History Of Cyclical PerformancePast losses and negative cash flow demonstrate that the current profitable cycle has not been consistent across periods. This history raises the risk that weaker marine demand, adoption timing or operating conditions could again pressure earnings and liquidity.
Single-product ConcentrationDependence on one core ingredient concentrates product, regulatory and commercialization risk. Delayed approvals, slower coating adoption or technical challenges affecting Selektope could have an outsized effect because the business has limited disclosed product diversification.

ITECH FAQ

What was I-Tech AB’s price range in the past 12 months?
I-Tech AB lowest stock price was kr42.20 and its highest was kr103.00 in the past 12 months.
    What is I-Tech AB’s market cap?
    I-Tech AB’s market cap is kr866.24M.
      When is I-Tech AB’s upcoming earnings report date?
      I-Tech AB’s upcoming earnings report date is Oct 16, 2026 which is in 38 days.
        How were I-Tech AB’s earnings last quarter?
        I-Tech AB released its earnings results on Aug 21, 2026. The company reported kr1.5 earnings per share for the quarter, beating the consensus estimate of kr1 by kr0.5.
          Is I-Tech AB overvalued?
          According to Wall Street analysts I-Tech AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does I-Tech AB pay dividends?
            I-Tech AB pays a Notavailable dividend of kr1.25 which represents an annual dividend yield of 1.73%. See more information on I-Tech AB dividends here
              What is I-Tech AB’s EPS estimate?
              I-Tech AB’s EPS estimate is 1.2.
                How many shares outstanding does I-Tech AB have?
                I-Tech AB has 11,997,777 shares outstanding.
                  What happened to I-Tech AB’s price movement after its last earnings report?
                  I-Tech AB reported an EPS of kr1.5 in its last earnings report, beating expectations of kr1. Following the earnings report the stock price went up 5.114%.
                    Which hedge fund is a major shareholder of I-Tech AB?
                    Currently, no hedge funds are holding shares in SE:ITECH
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      I-Tech AB

                      I-Tech AB, a biotechnology firm established in Mölndal, Sweden, in 2000, focuses on creating and commercializing products to prevent biofouling. Their flagship innovation is Selektope, a unique bio-repellent ingredient engineered for marine coatings. This compound provides crucial protection against hard fouling on ships, primarily by temporarily stimulating the swimming behavior of barnacle larvae, thereby preventing them from attaching to coated surfaces. The company's primary clientele is the marine coatings industry.

                      I-Tech AB (ITECH) Earnings & Revenues

                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Polygiene AB
                      OrganoClick AB
                      Enzymatica AB
                      Corline Biomedical AB
                      Photocat A/S
                      Popular Stocks